Austar Lifesciences Limited (HKG:6118)
Hong Kong
· Delayed Price · Currency is HKD 0.770
-0.030 (-3.75%)
Apr 28, 2026, 4:08 PM HKT
Austar Lifesciences Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 33.81 | 16.08 | -113.47 | 87.46 | 277.3 | Upgrade
|
| Depreciation & Amortization | 49.18 | 47.46 | 39.63 | 33.81 | 29.62 | Upgrade
|
| Other Amortization | - | 6.16 | 5.92 | 3.2 | 2.35 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.2 | -4.1 | 0.3 | 0.72 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 1.09 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 3.81 | 31.89 | -3.21 | 6.24 | Upgrade
|
| Loss (Gain) on Equity Investments | - | -0.3 | -6.73 | -9.54 | -209.65 | Upgrade
|
| Other Operating Activities | 49.12 | 1.36 | 97.08 | 28.66 | 44.69 | Upgrade
|
| Change in Accounts Receivable | - | 35.7 | -39.46 | -299.98 | -259.11 | Upgrade
|
| Change in Inventory | - | 10.87 | 85.55 | 32.04 | -222.69 | Upgrade
|
| Change in Accounts Payable | - | -36.54 | -74.97 | 103.01 | 124.87 | Upgrade
|
| Change in Unearned Revenue | - | 17.44 | -200.8 | -83.33 | 145.51 | Upgrade
|
| Change in Other Net Operating Assets | - | -3.44 | 104.6 | 68.46 | -44.39 | Upgrade
|
| Operating Cash Flow | 132.1 | 98.81 | -62.65 | -37.93 | -103.45 | Upgrade
|
| Operating Cash Flow Growth | 33.70% | - | - | - | - | Upgrade
|
| Capital Expenditures | - | -20.49 | -69.24 | -117.11 | -100.57 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 2.07 | 0.17 | 0.05 | 0.17 | Upgrade
|
| Cash Acquisitions | - | 2.82 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -2.59 | -1.71 | -19.33 | -15.31 | Upgrade
|
| Investment in Securities | - | 9 | 4.51 | -21.86 | 164.26 | Upgrade
|
| Other Investing Activities | -12.95 | 13.63 | 11.8 | 5.1 | 16.47 | Upgrade
|
| Investing Cash Flow | -12.95 | 4.43 | -54.47 | -153.14 | 65.02 | Upgrade
|
| Long-Term Debt Issued | - | 303.14 | 442.36 | 246.88 | 109.1 | Upgrade
|
| Total Debt Issued | - | 303.14 | 442.36 | 246.88 | 109.1 | Upgrade
|
| Long-Term Debt Repaid | - | -387.56 | -271.76 | -116.39 | -45.35 | Upgrade
|
| Total Debt Repaid | - | -387.56 | -271.76 | -116.39 | -45.35 | Upgrade
|
| Net Debt Issued (Repaid) | - | -84.43 | 170.6 | 130.49 | 63.75 | Upgrade
|
| Other Financing Activities | -57.91 | -16.9 | -23.49 | -5.19 | -4.4 | Upgrade
|
| Financing Cash Flow | -57.91 | -101.32 | 147.12 | 125.3 | 59.35 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 1.13 | 0.14 | 0.95 | -0.42 | Upgrade
|
| Net Cash Flow | 61.24 | 3.04 | 30.14 | -64.82 | 20.5 | Upgrade
|
| Free Cash Flow | 132.1 | 78.31 | -131.88 | -155.04 | -204.02 | Upgrade
|
| Free Cash Flow Growth | 68.69% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 8.63% | 5.22% | -7.48% | -7.19% | -10.13% | Upgrade
|
| Free Cash Flow Per Share | 0.26 | 0.15 | -0.26 | -0.30 | -0.40 | Upgrade
|
| Cash Interest Paid | - | 17.15 | 13.86 | 9.36 | 4.4 | Upgrade
|
| Cash Income Tax Paid | - | 6.88 | 7.4 | 15.69 | 7.81 | Upgrade
|
| Levered Free Cash Flow | 141.1 | 56.33 | -88.74 | -182.04 | -237.32 | Upgrade
|
| Unlevered Free Cash Flow | 148.57 | 66.97 | -80.01 | -176.04 | -234.56 | Upgrade
|
| Change in Working Capital | - | 24.03 | -125.07 | -179.81 | -255.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.